Prestige Wealth Management Group’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$908 Hold
45
﹤0.01% 930
2026
Q1
$765 Hold
45
﹤0.01% 907
2025
Q4
$763 Sell
45
-1,406
-97% -$25K ﹤0.01% 907
2025
Q3
$26.2K Hold
1,451
0.01% 331
2025
Q2
$23K Hold
1,451
﹤0.01% 336
2025
Q1
$24.5K Hold
1,451
0.01% 324
2024
Q4
$24.6K Hold
1,451
0.01% 332
2024
Q3
$26.3K Hold
1,451
0.01% 316
2024
Q2
$23.9K Buy
1,451
+45
+3% +$689 0.01% 300
2024
Q1
$19.9K Hold
1,406
﹤0.01% 342
2023
Q4
$24.2K Sell
1,406
-20
-1% -$305 0.01% 321
2023
Q3
$21.8K Buy
1,426
+20
+1% +$355 0.01% 327
2023
Q2
$26.5K Hold
1,406
0.01% 334
2023
Q1
$27.2K Hold
1,406
0.01% 298
2022
Q4
$27.1K Sell
1,406
-246
-15% -$4.83K 0.01% 315
2022
Q3
$34K Buy
1,652
+213
+15% +$5.41K 0.01% 259
2022
Q2
$40K Buy
+1,439
New +$42.7K 0.01% 257

Other funds holding HR

Prestige Wealth Management Group's HR Position: Q2 2026 in Review

Prestige Wealth Management Group held its Healthcare Realty (HR) position steady in Q2 2026 at 45 shares worth $908. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Prestige Wealth Management Group first reported a position in HR in Q2 2022 and has held it in 17 quarters since. The position peaked at $40K in Q2 2022. 458 funds tracked by Wall St. Rank hold HR as of Q2 2026.

  • Prestige Wealth Management Group held 45 shares of Healthcare Realty worth $908 as of Q2 2026.
  • Prestige Wealth Management Group left its Healthcare Realty share count unchanged in Q2 2026.
  • Healthcare Realty made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #930 holding.
  • Prestige Wealth Management Group first reported a position in Healthcare Realty in Q2 2022 and has held it in 17 quarters since.
  • Prestige Wealth Management Group's Healthcare Realty position peaked at $40K in Q2 2022.
  • 458 funds tracked by Wall St. Rank held Healthcare Realty as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.